Skip to content

GeneDx Holdings WGS Income Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$442.68M+34.1%$427.54M+40.0%$402.19M+50.5%$362.32M+48.7%$330.14M+48.8%
$134.77M+17.5%$129.37M+16.5%$122.08M+12.7%$118.91M+10.8%$114.68M+4.6%
$307.91M+42.9%$298.17M+53.4%$280.11M+76.2%$243.41M+78.5%$215.46M+92.1%
69.6%+4.3pp69.7%+6.1pp69.6%+10.2pp67.2%+11.2pp65.3%+14.7pp
$79.25M+69.6%$72.03M+57.5%$59.07M+27.4%$50.91M+3.9%$46.73M-15.4%
-$2.62M+14.9%-$2.54M+16.3%-$2.72M-$3M-$3.08M
-$11.48M+52.7%-$8.06M+72.6%-$7.46M-$3.9M-$24.29M
-$77.81M-$21.02M
-17.6%-4.9%
-$39.64M$12.15M
-9%2.8%
-$66M-$13.08M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are GeneDx Holdings's profit margins?
Gross margin is 69.6% and operating margin is -14.9%, with a -17.6% net margin.
Where does GeneDx Holdings's income statement data come from?
Every line is extracted from GeneDx Holdings's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.